Epizon Pharma, Inc.

États‑Unis d’Amérique


Commandez votre montre hebdomadaire Epizon Pharma, Inc.
Quantité totale PI 35
Rang # Quantité totale PI 42 558
Note d'activité PI 2,2/5.0    20
Rang # Activité PI 41 710
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

21 3
5 0
6 0
0
 
Dernier brevet 2026 - Pegylated menaquinol composition...
Premier brevet 2019 - Methods and compositions for pre...
Dernière marque 2019 - EPIZON PHARMA
Première marque 2015 - EPIZON

Industrie (Classification de Nice)

Derniers inventions, produits et services

2025 Invention Pegylated menaquinol compositions and methods of treatment. The present application discloses, i...
Invention Methods and compositions for preventing or treating tissue calcification. The invention provides...
2024 Invention Nano-particles of menaquinone and methods of treatment. The present application discloses composi...
Invention Nano-particles of menaquinone and methods of treatment
2023 Invention Methods and compositions for preventing or treating calciphylaxis. The invention provides methods...
Invention Methods and compositions for preventing or treating tissue calcification. The invention provides ...
Invention Pegylated menaquinol compositions and methods of treatment. The present application discloses, in...
Invention Pegylated menaquinol compositions and methods of treatment. La présente invention concerne, en pa...
2022 Invention Menaquinol compositions and methods of treatment. The present application discloses methods for t...
2021 Invention Compositions of biologically active menaquinol derivatives and methods of treatment. The present ...
2019 P/S pharmaceutical preparations for the treatment of vascular disease, cardiovascular disease, heart ...
Invention Use of menaquinone07 or menaquinol-7 for preventing or treating calciphylaxie. The invention prov...
Invention Methods and compositions for preventing or treating tissue calcification. e.ge.ge.ge.g., slowing ...
Invention Methods and compositions for preventing or treating calciphylaxis. e.ge.g., slowing the progressi...
2015 P/S development of pharmaceutical preparations and medicines; pharmaceutical products development; ph...